Exclusif: Vers une scission d'En Marche à l'Assemblée

https://www.challenges.fr/politique/le-depute-alain-tourret-veut-creer-un-nouveau-groupe-a-l-assemblee-pour-reunir-les-radicaux-d-en-marche_502499

Exclusif: Vers une scission d'En Marche à l'Assemblée

Le député (En marche) Alain Tourret projette la création d'un nouveau groupe parlementaire qui réunira des radicaux de gauche et de droite. Un projet qui porte en germe la fragmentation du groupe En Marche à l'Assemblée Nationale.

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance:
  • KRNT -20.4%, NKE -3.5%, ARCW -2.1%, (also announces initial results from strategic operating review), ATU -1.3%
Other news:
  • ITCI -7.2% (commences an underwritten public offering of $150 mln of shares of its common stock)
  • ASND -2.3% (commences public offering of $125 mln of American Depositary Shares, each of which represents one ordinary share of Ascendis )
  • FINL -1.6% (following NKE earnings)
  • SONC -1% (Krebs report of security breach)
Analyst comments:
  • SPWR -3.3% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
  • TRVG -1.9% (downgraded to Neutral from Overweight at JP Morgan)
  • TTS -2.7% (downgraded to Neutral from Overweight at Piper Jaffray)
  • WBA -0.7% (downgraded to Mkt Perform from Outperform at Raymond James)
  • CLXT -2.4% (downgraded to Neutral from Buy at Citigroup)

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:
  • MU +5.5%, LNDC +4.8%, FWP +4.8%, HUBS +1.9%
M&A news:
  • TMUS +1.9% (to acquire the remaining interest of Iowa Wireless from Aureon)
Other news:
  • AVGR +194.7% (confirms CE Marking approval for treating in-stent restenosis with the Pantheris Lumivascular atherectomy system), IMNP+85% (announces prelim results from the first six subjects enrolled in its ongoing, open-label phase 2 study of bertilimumab), MARK +38.5% (awarded a seven-figure contract by one of the largest state-owned enterprises in China to provide a facial and object recognition technology to a Shanghai municipal health agency), CALI +14.7% (entered into a Debt Exchange Agreement ), ZSAN +10.1% (received official written notification of USPTO regarding patent application 15/438,455 'Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines' ), WYY +7% (announced an award of Option Year 2 task order modification for cellular wireless managed services by United States Immigration and Customs Enforcement for approximately $9.3 million), CASC +5.4% (FDA granted orphan drug designation to tucatinib for the treatment of HER2-positive metastatic colorectal cancer), KEM +4.1% (KEMET will replace Astoria Financial in the S&P SmallCap 600), EDIT +3.7% (EMA granted Orphan Medicinal Product designation to EDIT-101, a pre-clinical, CRISPR-based medicinal product to treat Leber Congenital Amaurosis type 10), SIX+3.4% (Six Flags will replace PAREXEL in the S&P MidCap 400), TWTR+1.7% (Twitter to revise character limit among other items), RH +1.6% (Chairman/CEO discloses the purchase of 13,959 shares - transaction dates today), CTLT +1.5% (prices offering of 6,395,000 shares of common stock at $39.10 per share), AMGN +1.1% (Amgen and Simcere Pharmaceutical Group execute exclusive agreement to co-develop and commercialize four biosimilars in China; specific financial terms of the agreement were not disclosed), STL +1% (Sterling Bancorp will replace Oil States International in the S&P MidCap 400)
Analyst comments:
  • CDNA +7.8% (upgraded to Outperform from Mkt Perform at Raymond James)
  • ZEAL +5.6% (initiated with a Buy at Goldman)
  • PSO +5% (upgraded to Outperform from Underperform at Exane BNP Paribas)
  • LITE +3.9% (upgraded to Buy from Neutral at MKM Partners)
  • VSLR +3.1% (initiated with a Buy at Guggenheim)
  • KORS +2.4% (upgraded to Buy from Hold at Canaccord Genuity)
  • TEF +2.1% (upgraded to Buy from Hold at Berenberg)
  • RBS +2% (upgraded to Buy from Hold at Jefferie)
  • DRI +1.3% (upgraded to Outperform from Neutral at Robert W. Baird)
  • BABA +1.1% (resumed with a Outperform at Wells Fargo),
  • IDU +1% (initiated with a Outperform at Wells Fargo)
  • EBAY +0.9% (resumed with a Outperform at Wells Fargo)
  • JD +0.8% (initiated with a Outperform at Wells Fargo)
  • AMZN +0.8% (resumed with a Outperform at Wells Fargo)
  • NFLX +0.7% (initiated with a Outperform at Wells Fargo)
Gapping down
In reaction to disappointing earnings/guidance:
  • KRNT -20.4%, NKE -3.5%, ARCW -2.1%, (also announces initial results from strategic operating review), ATU -1.3%

(Canaccord) Michael Kors upgradeto Buy tgt raised to $58

Michael Kors upgradeto Buy tgt raised to $58
Canaccord Genuity upgrades KORS to Buy from Hold and raises their tgt to $58 from $43 noting, "After a multi-year stretch of excessive promotions, stale innovation in handbags, and a watch category that disproportionately depressed comps and collapsed EBIT margins, we believe the strategic steps management has recently begun implementing are showing early signs of traction. We believe the turn KORS management is orchestrating will result in a multi-step P&L march upward that will manifest through both comps and gross margins over the next few years . . ."